Tuesday, July 14, 2026

11:15 AM - 1:15 PM

---

Details

Breastfeeding is the most affordable, feasible, acceptable, sustainable and safe feeding option for infant and mother. Breastfeeding women are found in every society around the world, and more than half of these will require some form of medication whilst breastfeeding. For many medications, lactation pharmacology studies have not been performed and decisions on risks and benefits to the mother-infant dyad are made ‘in the dark’. This is unacceptable. In this symposium, we bring to together three leading consortia that use innovative clinical, analytical, pharmacometrics, and real-world evidence approaches to fill critical gaps in evidence. The MPRINT (Maternal Pediatric PRecision in Therapeutics) Hub, the ConcePTION Project (lactation related WP3) and the MILK (Maternal and Infant Lactation pharmacoKinetics) group explore infant exposure to medications through lactation. Efforts aim to support regulatory pathways and decisions, drug labelling, and to inform clinical therapy of lactating patients and their children.

---

Session chair